Penninkhof Joan, Fremeijer Kimm, Offereins-van Harten Kirsten, van Wanrooij Cynthia, Quint Sandra, Kunnen Britt, Hoffmans-Holtzer Nienke, Swaak Annemarie, Baaijens Margreet, Dirkx Maarten
Department of Radiation Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Tech Innov Patient Support Radiat Oncol. 2022 Feb 17;21:51-57. doi: 10.1016/j.tipsro.2022.02.001. eCollection 2022 Mar.
Nowadays, deep inspiratory breath-hold is a common technique to reduce heart dose in left-sided breast radiotherapy. This study evaluates the evolution of the breath-hold technique in our institute, from portal imaging during dose delivery to continuous monitoring with surface-guided radiotherapy (SGRT).
Setup data and portal imaging results were analyzed for 98 patients treated before 2014, and SGRT data for 228 patients treated between 2018 and 2020. For the pre-SGRT group, systematic and random setup errors were calculated for different correction protocols. Residual errors and reproducibility of breath-holds were evaluated for both groups. The benefit of using SGRT for initial positioning was evaluated for another cohort of 47 patients.
Online correction reduced the population mean error from 3.9 mm (no corrections) to 1.4 mm. Despite online setup correction, deviations greater than 3 mm were observed in about 10% and 20% of the treatment beams in ventral-dorsal and cranial-caudal directions, respectively. However, these percentages were much smaller than with offline protocols or no corrections. Mean absolute differences between breath-holds within a fraction were smaller in the SGRT-group (1.69 mm) than in the pre-SGRT-group (2.10 mm), and further improved with addition of visual feedback (1.30 mm). SGRT for positioning did not improve setup accuracy, but slightly reduced the time for imaging and setup correction, allowing completion within 3.5 min for 95% of fractions.
For accurate radiotherapy breast treatments using deep inspiration breath-hold, daily imaging and correction is required. SGRT provides accurate information on patient positioning during treatment and improves patient compliance with visual feedback.
如今,深吸气屏气是左侧乳腺癌放疗中降低心脏剂量的常用技术。本研究评估了我院屏气技术的演变,从剂量输送过程中的门静脉成像到表面引导放疗(SGRT)的连续监测。
分析了2014年前接受治疗的98例患者的设置数据和门静脉成像结果,以及2018年至2020年间接受治疗的228例患者的SGRT数据。对于SGRT前组,计算了不同校正方案的系统和随机设置误差。评估了两组屏气的残余误差和可重复性。对另一组47例患者评估了使用SGRT进行初始定位的益处。
在线校正将总体平均误差从3.9毫米(无校正)降低到1.4毫米。尽管进行了在线设置校正,但在腹背和头脚方向上,分别约有10%和20%的治疗射束观察到偏差大于3毫米。然而,这些百分比远低于离线方案或无校正的情况。SGRT组内分次屏气之间的平均绝对差异(1.69毫米)小于SGRT前组(2.10毫米),并通过添加视觉反馈进一步改善(1.30毫米)。用于定位的SGRT没有提高设置精度,但略微减少了成像和设置校正的时间,95%的分次能够在3.5分钟内完成。
对于使用深吸气屏气进行准确的乳腺癌放疗,需要每日成像和校正。SGRT在治疗期间提供有关患者定位的准确信息,并通过视觉反馈提高患者的依从性。